Nature Biotechnology shared a research highlight titled “On-demand glycemic control by engineered bacteria.”
Nature Biotechnology highlighted research on engineered bacteria and on-demand blood sugar control.
1.3K
1 Source, first seen 1h ago
Not enough discussion yet.
No sentiment analysis available yet.
Not enough discussion yet.
No sentiment analysis available yet.
—
Not ranked yet
—
Not ranked yet
Nature Biotechnology reports that many of the proteins appear relevant to human health. Its story focuses on startups mining the “dark proteome” for drug targets.
Nature Biotechnology describes lipid nanoparticles improved by accounting for RNA cargo size during design.
